AI Scrapes 150,000 Forum Posts to Flag Black-Market Peptide Risks

When people bypass clinical supervision to acquire unlicensed metabolic drugs, regulatory adverse-event reporting systems go blind. A research team used natural language processing to inspect 148,582 public discussion posts from online forums where individuals documented self-directed regimens of retatrutide, an unapproved triple-hormone receptor agonist. Rather than the predictable satiety documented in controlled phase 2 trials, the computational review surfaced spikes in resting heart rates, sleep fragmentation, and paradoxically heightened hunger during dosage escalations.

Formal phase 2 data for retatrutide—evaluating doses up to 12 mg weekly across 338 participants—established substantial average weight loss alongside transient nausea. Yet real-world self-administration relies on grey-market peptide suppliers, variable reconstitution purity, and improvised titration schedules. Language models categorized recurring clusters of somatic complaints across these unregulated cohorts, isolating patterns of tachycardia that individuals frequently brushed aside as normal acclimation.

If you track resting pulse or sleep continuity with consumer wearables while experimenting with novel metabolic therapies, treat unexpected deviations as immediate physiological strain rather than noise. Bring raw sensor logs directly to an independent physician, check verified compound purity reports before self-administering any analogue, and never assume an online protocol mirrors clinical safety.